Diligence memo · auto-generated · as of July 3, 2026

Outpost Medicine, LLC

Outpost Medicine, LLC looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Outpost Medicine, LLC operates in Other, based in Indianapolis.

Sector still resolves to a broad 'Other' bucket, so operating comparables below are weaker than for a tightly-classified peer.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Outpost Medicine, LLC has raised $72M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).

Largest single filing: $56M on 2017-05-15.

Most recent recorded round closed around 2017-05-15.

Valuation (modeled)modeled

Provath models Outpost Medicine, LLC at approximately $960M (range $217M–$2.5B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.11× the median modeled value of Series C Other companies in 2016–2018 (135 peers) — value vs value, same stage and era. Within the normal band (111% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 7 months.

Last raise 9.1 yr ago; this sector typically re-raises about every 11 months.

Silent for over 3× the sector's normal cadence.

The last round was 3.7× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 95% of Other peers (25015 compared).

Modeled value ranks above 97% of those peers.

Closest niche peers: C.K. Futures, Llc, Corey Moffitt Trust, Blockvest LLC, Mel Investment Holdings, Llc, Nash Holdings, Inc. (Robert Nash, President).

Peoplefiled

8 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Broad sector classification weakens peer comparison.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.